Suraksha Diagnostics has announced a strategic investment of Rs. 200 crore to establish more than 20 state-of-the-art imaging centres across eastern India, reinforcing its commitment to delivering quality diagnostic services beyond metro regions. Partnering with global technology firm United Imaging, the initiative will focus on expanding diagnostic access in tier-2 and tier-3 cities, enhancing affordability and clinical accuracy in underserved areas. This move follows the company’s successful Rs. 846.25 crore IPO in December, earmarked for expansion. Suraksha Diagnostics currently operates a robust network of diagnostic and sample collection centres across West Bengal, Bihar, Assam, and Meghalaya.
Strategic Investment to Broaden Healthcare Access
In a significant development aimed at transforming regional diagnostics, Suraksha Diagnostics has pledged Rs. 200 crore to set up over 20 advanced imaging centres in eastern India. While the exact timeline for the rollout remains undisclosed, the strategic vision is clear: bridge the urban-rural diagnostic divide by bringing sophisticated healthcare technology to smaller towns.
The expansion will primarily benefit populations in tier-2 and tier-3 cities—areas often underserved in terms of reliable imaging and pathology services. This move is expected to significantly improve early detection, disease management, and healthcare outcomes for millions.
Technology Partnership with United Imaging
To support this ambitious expansion, Suraksha Diagnostics has entered a collaboration with United Imaging, a globally renowned medical imaging technology company. Under the terms of the partnership, United Imaging will supply high-end imaging solutions, including MRI and CT scanning systems, to power the new centres.
Suraksha Diagnostics, meanwhile, will contribute its operational experience and existing market infrastructure to ensure effective execution and service delivery. The fusion of world-class technology with regional healthcare knowledge aims to raise the bar for diagnostic accuracy and accessibility across eastern India.
Funding Fuelled by IPO Success
The investment follows Suraksha Diagnostics’ successful initial public offering in December, which raised Rs. 846.25 crore. A substantial portion of this capital has been allocated specifically for expansion and technological upgrades.
The decision to channel a segment of IPO proceeds into tier-2 and tier-3 infrastructure aligns with investor expectations for sustainable, inclusive growth and reflects the company’s long-term strategy of balancing profitability with public health impact.
Expanding Regional Presence and Operational Footprint
Currently, Suraksha Diagnostics operates 59 diagnostic centres and 166 sample collection centres, primarily concentrated in West Bengal, Bihar, Assam, and Meghalaya. With this latest investment, the company is poised to significantly increase its regional footprint, thereby reinforcing its leadership in eastern India's diagnostic services market.
The targeted approach toward semi-urban and rural clusters not only strengthens the company’s market positioning but also aligns with broader healthcare policy goals of decentralizing quality medical care.
Implications for the Healthcare Ecosystem
Suraksha’s expansion plan is particularly timely as India witnesses growing demand for preventive healthcare and accurate, early-stage diagnosis in non-metro regions. The investment promises to boost diagnostic capacity and enable faster turnaround times, particularly in areas where diagnostic delays often compromise treatment efficacy.
Moreover, by leveraging advanced imaging technology, the centres are likely to reduce dependence on centralized urban hospitals for complex tests, thus democratizing access to critical healthcare infrastructure.
Comments